The Journal of Urology
Volume 181, Issue 4 , Pages 1642-1657, April 2009

Use of 5α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline

National Institutes of Health, Bethesda, MD; American Society of Clinical Oncology, Alexandria, VA; University of Montana Liberal Studies, Missoula, MT; University of Connecticut Health Center, Farmington, CT; International Epidemiology Institute, Rockville, MD; Johns Hopkins University, Baltimore, MD; National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; University of North Carolina at Chapel Hill, Chapel Hill, NC; University of Minnesota School of Medicine, Minneapolis, MN; Statistics Collaborative,Washington, DC; Michiana Hematology Oncology, Granger, IN; and Eastern Virginia Medical School, Norfolk, VA

published online 26 February 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Approved by the American Society of Clinical Oncology Board on July 21, 2008, and by the American Urological Association Board on October 17, 2008.

 This document is being reprinted as submitted without editorial or independent peer review by the Editors of The Journal of Urology®.

 This guideline was developed through a collaboration between the American Society of Clinical Oncology and the American Urological Association, and has been published jointly by invitation and consent in the Journal of Clinical Oncology and The Journal of Urology®. No part of this document may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording or any information storage and retrieval system, without written permission by the American Society of Clinical Oncology or the American Urological Association.

 See Editorial on page 1530.For another article on a related topic see page 1907.

PII: S0022-5347(09)00172-4

doi:10.1016/j.juro.2009.01.071

Refers to article:

  • A Guideline for Discussion and Some Thoughts , 26 February 2009

    Michael J. Droller
    The Journal of Urology April 2009 (Vol. 181, Issue 4, Pages 1530-1531)

  • Bcl2 −938C/A Polymorphism Carries Increased Risk of Biochemical Recurrence After Radical Prostatectomy , 23 February 2009

    Hiroshi Hirata, Yuji Hinoda, Nobuyuki Kikuno, Yutaka Suehiro, Varahram Shahryari, Ardalan E. Ahmad, Z. Laura Tabatabai, Mikio Igawa, Rajvir Dahiya
    The Journal of Urology April 2009 (Vol. 181, Issue 4, Pages 1907-1912)

The Journal of Urology
Volume 181, Issue 4 , Pages 1642-1657, April 2009

Article Tools

* Image Usage & Resolution